Abstract
Cardiovascular disease is the main cause of death in the United States. Although it is recognized that moderate intensity long-term exercise can decrease the chances of dying from cardiovascular disease by favorably modifying risk factors such as hypertension, obesity, hyperlipidemia, and insulin resistance, physical activity also enhances longevity by mechanisms independent of these risk factors. This review briefly summarizes what is known about the inflammatory nature of atherosclerosis and how long-term aerobic exercise can reduce the atherogenic activity of endothelial cells, blood mononuclear cells, and adipose tissue.
Keywords: Exercise, cardiovascular disease, cardiorespiratory fitness, atherogenesis, vascular endothelial cells, peripheral blood mononuclear cells, adipose tissue, inflammation, cell-mediated immunity, hypertension, obesity, hyperlipidemia, insulin resistance, immunopathogenesis, vascular endothelial cells (VEC), Chlamydia pneumoniae, cytomegalovirus, heat shock protein 60 (Hsp 60), chemokines, prostacyclin PGI2, adrenomedullin, granulopoiesis, immunogens, metalloproteinases, phosphorylation, eNOS protein, adipocytes, lymphocytes, fibroblasts, adipokines, monocytes
Cardiovascular & Hematological Disorders-Drug Targets
Title: Exercise and Cardiovascular Disease
Volume: 10 Issue: 4
Author(s): J. Kelly Smith
Affiliation:
Keywords: Exercise, cardiovascular disease, cardiorespiratory fitness, atherogenesis, vascular endothelial cells, peripheral blood mononuclear cells, adipose tissue, inflammation, cell-mediated immunity, hypertension, obesity, hyperlipidemia, insulin resistance, immunopathogenesis, vascular endothelial cells (VEC), Chlamydia pneumoniae, cytomegalovirus, heat shock protein 60 (Hsp 60), chemokines, prostacyclin PGI2, adrenomedullin, granulopoiesis, immunogens, metalloproteinases, phosphorylation, eNOS protein, adipocytes, lymphocytes, fibroblasts, adipokines, monocytes
Abstract: Cardiovascular disease is the main cause of death in the United States. Although it is recognized that moderate intensity long-term exercise can decrease the chances of dying from cardiovascular disease by favorably modifying risk factors such as hypertension, obesity, hyperlipidemia, and insulin resistance, physical activity also enhances longevity by mechanisms independent of these risk factors. This review briefly summarizes what is known about the inflammatory nature of atherosclerosis and how long-term aerobic exercise can reduce the atherogenic activity of endothelial cells, blood mononuclear cells, and adipose tissue.
Export Options
About this article
Cite this article as:
Kelly Smith J., Exercise and Cardiovascular Disease, Cardiovascular & Hematological Disorders-Drug Targets 2010; 10 (4) . https://dx.doi.org/10.2174/187152910793743823
DOI https://dx.doi.org/10.2174/187152910793743823 |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Oxidative stress and myocarditis
Current Pharmaceutical Design Modulation of Heart Rate by Acute or Chronic Aerobic Exercise. Potential Effects on Blood Pressure Control
Current Pharmaceutical Design Is Elevated Norepinephrine an Etiological Factor in Some Cases of Alzheimers Disease?
Current Alzheimer Research Types of Voltage-Gated Calcium Channels: Molecular and Electrophysiological Views
Current Hypertension Reviews Potential Targets for Intervention in Radiation-Induced Heart Disease
Current Drug Targets Angiogenic Growth Factors in the Treatment of Peripheral Arterial Disease
Current Vascular Pharmacology Fetal Mechanisms That Lead to Later Hypertension
Current Drug Targets Patent Selections
Recent Patents on Biotechnology Genetic Variant-Associated Endothelial Dysfunction Behind Small-Vessel Cerebral Circulatory Disorders: A New Pathomechanism Behind Common Cerebral Phenotypes
Mini-Reviews in Medicinal Chemistry Targeting Transient Receptor Potential Channels in Cardiometabolic Diseases and Myocardial Ischemia Reperfusion Injury
Current Drug Targets Renal Complications of Fabry Disease
Current Pharmaceutical Design Diagnostic and Therapeutic Potentials of microRNAs in Heart Failure
Current Topics in Medicinal Chemistry Leptin and the Ob-Receptor as Anti-Obesity Target: Recent In Silico Advances in the Comprehension of the Protein-Protein Interaction and Rational Drug Design of Anti- Obesity Lead Compounds
Current Pharmaceutical Design The Optimal Treatment of Severe Hypertension in Pregnancy: Update of the Role of Nicardipine
Current Pharmaceutical Biotechnology TGF-beta Signaling in Cancer Treatment
Current Pharmaceutical Design Plasma Potassium Levels in Healthy Prehypertension Subjects and the Role of A High Potassium Drink
Current Hypertension Reviews Pharmacological and Non Pharmacological Strategies in the Management of Coronary Artery Disease and Chronic Kidney Disease
Current Cardiology Reviews Xanthine Oxidase Perspective in Human Health
Current Biotechnology The Overlap Between Binge Eating Behaviors and Polycystic Ovarian Syndrome: An Etiological Integrative Model
Current Pharmaceutical Design Acute Fulminant Hepatatis in Kidney Transplant Recipient After Repeated Sevoflurane Anesthesia - A Case Report and Literature Review
Current Drug Safety